Advertisements


Aldeyra Looks To Add To Its Extensive Pipeline Treating Eye Diseases

Aldeyra Looks To Add To Its Extensive Pipeline Treating Eye Diseases.....»»

Category: topSource: seekingalphaFeb 11th, 2019

Adaptive Biotechnologies prices IPO at $20 a share, above previous range of $18 to $19

Adaptive Biotechnologies Corp. , a life-sciences research and clinical diagnostics company that says data from the immune system is the key to diagnosing and treating diseases, h.....»»

Category: topSource: marketwatchJun 27th, 2019

BridgeBio Pharma IPO: What You Need To Know

The week will see the listing of a late entrant into the arena, but it nonetheless has an impressive pipeline of investigational assets targeting genetic diseases. read more.....»»

Category: blogSource: benzingaJun 26th, 2019

Akari"s Lead Candidate Found Safe, Effective In Treating Eye Inflammation

Shares of Akari Therapeutics PLC (NASDAQ: AKTX) — a thinly traded nano-cap biotech focusing on therapies for autoimmune and inflammatory diseases — were soaring Wednesday.  read more.....»»

Category: blogSource: benzingaJun 19th, 2019

Adaptive Biotechnologies IPO: Five things to know

Adaptive Biotechnologies Corp., a life-sciences research and clinical diagnostics company that says data from the immune system is the key to diagnosing and treating diseases, is planning to go public......»»

Category: topSource: marketwatchJun 10th, 2019

Did Hedge Funds Drop The Ball On Plains All American Pipeline, L.P. (PAA) ?

Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why.....»»

Category: topSource: insidermonkeyMar 31st, 2019

Aldeyra"s Eye Drug Meets Main Goal in Study, Shares Surge

Aldeyra (ALDX) announced positive top-line data from a phase III study on pipeline product, reproxalap topical ophthalmic solution in patients with a.....»»

Category: smallbizSource: nytMar 27th, 2019

Why a strong IPR regime matters

There are still unmet medical needs in India. Better protection for intellectual property will help bring new solutions for treating patients suffering from critical diseases.....»»

Category: topSource: business-standardMay 5th, 2018

Treating Genetic Diseases in Utero Could Change the CRISPR Space

CRISPR stocks have been plagued with clinical holds by the FDA. But what if the treatments these speculative companies are working on can be applied in utero? New research shows they canRelated Stocks: CRSP, EDIT, NTLA,.....»»

Category: blogSource: gurufocusOct 14th, 2018

Israel To Export Gas To Egypt In Bid To Create East Mediterranean "Energy Export Hub"

Israel has confirmed it is in extensive talks with Egypt to build a new sub-sea natural gas pipeline between the two countries as part of a previously agreed $15 billion deal to export Israe.....»»

Category: blogSource: zerohedgeJan 16th, 2019

Axovant Announces Third Fiscal Quarter 2018 Financial Results and Corporate Updates

Expanded pipeline with two investigational gene therapy programs licensed from the University of Massachusetts Medical School for the treatment of GM1 gangliosidosis, Tay-Sachs and Sandhoff diseases First two patients dosed in SUNRISE-PD phase 2 t.....»»

Category: earningsSource: benzingaFeb 7th, 2019

Richard Branson"s Virgin Trains USA lists Pacific Northwest rail in "potential expansion pipeline"

The billionaire's business jet also landed in Seattle after Virgin Trains USA expressed interest in Portland-Seattle-Vancouver, British Columbia railway......»»

Category: topSource: bizjournals12 hr. 36 min. ago

Merck stock up slightly after FDA approves Recarbrio for new indication

Shares of Merck & Co Inc. ticked up 0.5% in premarket trade Wednesday after the company said the U.S. Food and Drug Administration had approved its antibacterial Recarbrio injection for use in treating complicated .....»»

Category: topSource: marketwatch20 hr. 36 min. ago

Antares Pharma"s Stellar XYOSTED Launch And Pipeline Growth Should Outweigh Management Woes

Antares Pharma"s Stellar XYOSTED Launch And Pipeline Growth Should Outweigh Management Woes.....»»

Category: topSource: seekingalphaJul 16th, 2019

Evogene Tackles Corn Crop Fungal Diseases With Bayer

Evogene Ltd. (NASDAQ: EVGN) is amending its collaboration with Bayer AG (OTC: BAYRY)'s crop science division to identify genome editing targets for evaluation against a broad range of corn diseases. read more.....»»

Category: blogSource: benzingaJul 16th, 2019

After Aliso Canyon, a gas pipeline exploded — costing Californians $1 billion

Two years after methane gas began leaking from Southern California Gas Co.'s Aliso Canyon storage field, one of the company's key pipelines exploded, starting a fire in the desert and leaving a sm.....»»

Category: topSource: latimesJul 16th, 2019

Would you choose space or style in Santa Monica?

In the high-caliber housing market of Los Angeles, every neighborhood brandishes a distinct style, offering an extensive list of pros and cons that ca.....»»

Category: topSource: latimesJul 16th, 2019

JPMorgan CFO says overall IB pipeline is "healthy"

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 16th, 2019

Energy Transfer considering sale of 33% Rover pipeline stake, Bloomberg says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 15th, 2019

Genmab IPO: What You Need To Know

An OTC-listed large-cap biotech is seeking a main exchange listing, and it offers scope for investing in a proven biotech with two commercial partnered products on the market and more in the pipeline. read more.....»»

Category: blogSource: benzingaJul 15th, 2019

Regeneron"s Blockbuster New Launches And Innovative Pipeline Will Outweigh Eylea Biosimilar Competition

Regeneron"s Blockbuster New Launches And Innovative Pipeline Will Outweigh Eylea Biosimilar Competition.....»»

Category: topSource: seekingalphaJul 15th, 2019